Cécile Dalban

3.0k total citations
74 papers, 1.6k citations indexed

About

Cécile Dalban is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Infectious Diseases. According to data from OpenAlex, Cécile Dalban has authored 74 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pulmonary and Respiratory Medicine, 35 papers in Oncology and 11 papers in Infectious Diseases. Recurrent topics in Cécile Dalban's work include Renal cell carcinoma treatment (24 papers), Cancer Immunotherapy and Biomarkers (20 papers) and HIV Research and Treatment (7 papers). Cécile Dalban is often cited by papers focused on Renal cell carcinoma treatment (24 papers), Cancer Immunotherapy and Biomarkers (20 papers) and HIV Research and Treatment (7 papers). Cécile Dalban collaborates with scholars based in France, Belgium and United States. Cécile Dalban's co-authors include Julien Taı̈eb, Touraj Mansourbakht, Dominique Costagliola, Maximilien Barret, David Malka, Aziz Zaanan, S. Antoun, Franck Bonnetain, Stéphane Blanche and Pierre Quartier and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Cécile Dalban

72 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cécile Dalban France	22	448	372	365	257	250	74	1.6k
Lanfang Xu United States	24	1.0k 2.3×	562 1.5×	240 0.7×	290 1.1×	102 0.4×	62	2.4k
Lesley S. Park United States	19	543 1.2×	642 1.7×	121 0.3×	182 0.7×	83 0.3×	36	1.7k
Katherine Van Loon United States	21	956 2.1×	99 0.3×	267 0.7×	270 1.1×	103 0.4×	126	1.7k
David M. Mintzer United States	22	545 1.2×	372 1.0×	477 1.3×	229 0.9×	79 0.3×	60	2.3k
André Deeke Sasse Brazil	21	485 1.1×	284 0.8×	434 1.2×	218 0.8×	127 0.5×	78	1.5k
Claudia Biasini Italy	13	421 0.9×	92 0.2×	241 0.7×	105 0.4×	105 0.4×	24	1.3k
J. Ceccaldi France	13	311 0.7×	97 0.3×	188 0.5×	121 0.5×	385 1.5×	47	955
Neil A. Accortt United States	23	618 1.4×	218 0.6×	97 0.3×	212 0.8×	147 0.6×	55	1.9k
Pauline Rogers United Kingdom	25	336 0.8×	183 0.5×	319 0.9×	249 1.0×	154 0.6×	57	1.4k
Brian P. Mulhall Australia	18	262 0.6×	254 0.7×	147 0.4×	138 0.5×	105 0.4×	40	1.2k

Countries citing papers authored by Cécile Dalban

Since Specialization

Citations

This map shows the geographic impact of Cécile Dalban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cécile Dalban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cécile Dalban more than expected).

Fields of papers citing papers by Cécile Dalban

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cécile Dalban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cécile Dalban. The network helps show where Cécile Dalban may publish in the future.

Co-authorship network of co-authors of Cécile Dalban

This figure shows the co-authorship network connecting the top 25 collaborators of Cécile Dalban. A scholar is included among the top collaborators of Cécile Dalban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cécile Dalban. Cécile Dalban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dalban, Cécile, et al.. (2025). Nivolumab plasma concentration and clearance associated with overall survival in patients with renal cell carcinoma. Journal for ImmunoTherapy of Cancer. 13(1). e010059–e010059. 2 indexed citations

Négrier, Sylvie, Loı̈c Mourey, Ellen Blanc, et al.. (2025). Cabozantinib in patients (pts) with non-locally pretreated brain metastases (BM) from renal cell carcinoma (RCC): Results of the multicenter CABRAMET phase II trial (NCT03967522).. Journal of Clinical Oncology. 43(5_suppl). 533–533. 1 indexed citations

Dalban, Cécile, Marine Gross‐Goupil, Brigitte Laguerre, et al.. (2023). Association of Corticosteroids With Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With Nivolumab. JAMA Oncology. 9(9). 1295–1295. 4 indexed citations

Naigeon, Marie, Ronan Flippot, Cécile Dalban, et al.. (2023). 184P Elevated baseline circulating IL-8 is associated with increased expression of the IMmotion myeloid gene signature (GS) in metastatic clear cell renal cell carcinoma (mRCC) patients (pts) treated with nivolumab (nivo) within the NIVOREN GETUG-AFU 26 study. Immuno-Oncology Technology. 20. 100643–100643. 1 indexed citations

Kfoury, Maria, Domenica Lorusso, Anne Floquet, et al.. (2022). 528MO Is re-introduction or continuation of PARP inhibitors after local therapy for oligo-metastatic progression in patients with relapsed ovarian cancer relevant?. Annals of Oncology. 33. S787–S788. 3 indexed citations

Dufresne, Armelle, Olivier Huillard, Cécile Dalban, et al.. (2022). 465P Larotracking: Real-life study of locally advanced/metastatic solid tumor treated with larotrectinib in French expanded access program. Annals of Oncology. 33. S753–S753. 2 indexed citations

Rassy, Elie, Cécile Dalban, Émeline Colomba, et al.. (2022). Efficacy and Safety of Concomitant Proton Pump Inhibitor and Nivolumab in Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study. Clinical Genitourinary Cancer. 20(5). 488–494. 13 indexed citations

Kinget, Lisa, Eduard Roussel, Diether Lambrechts, et al.. (2021). 689P Human leukocyte antigen (HLA) class I/II expression as a predictive biomarker for response to immune oncology (IO) therapy in metastatic clear-cell renal cell carcinoma (m-ccRCC). Annals of Oncology. 32. S706–S706. 2 indexed citations

Derosa, Lisa, Cécile Dalban, Émeline Colomba, et al.. (2021). 697P Impact of β-blockers (BB) on outcomes of metastatic renal cell carcinoma (mRCC) patients treated with nivolumab (N). Annals of Oncology. 32. S710–S710. 5 indexed citations

10.

Dalban, Cécile, Brigitte Laguerre, Sylvain Ladoire, et al.. (2020). 712P Primary tumour response in patients treated with nivolumab for metastatic renal cell carcinoma (mRCC): Results of the GETUG-AFU 26 NIVOREN trial. Annals of Oncology. 31. S560–S561. 1 indexed citations

11.

Meylan, Maxime, Benoit Beuselinck, Cécile Dalban, et al.. (2020). 700O Kidney ccRCC immune classification (KIC) enhances the predictive value of T effector (Teff) and angiogenesis (Angio) signatures in response to nivolumab (N). Annals of Oncology. 31. S553–S553. 7 indexed citations

12.

Marec‐Bérard, Perrine, Cécile Dalban, Nathalie Gaspar, et al.. (2019). A multicentric randomized phase II clinical trial evaluating high-dose thiotepa as adjuvant treatment to standard chemotherapy in patients with resectable relapsed osteosarcoma. European Journal of Cancer. 125. 58–68. 21 indexed citations

13.

Fayet, Yohan, Jean‐Michel Coindre, Cécile Dalban, et al.. (2018). Geographical Accessibility of the Sarcoma Referral Networks in France. Intermediate Results from the IGéAS Research Program. International Journal of Environmental Research and Public Health. 15(10). 2204–2204. 13 indexed citations

14.

Schvartz, Claire, Cécile Dalban, A. Dalac, et al.. (2015). Prognostic Value of 18F-FDG PET/CT Metabolic Parameters in Metastatic Differentiated Thyroid Cancers. Clinical Nuclear Medicine. 40(6). 469–475. 26 indexed citations

15.

Pernot, Simon, Emmanuel Mitry, Emmanuelle Samalin, et al.. (2013). Biweekly docetaxel, fluorouracil, leucovorin, oxaliplatin (TEF) as first-line treatment for advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: safety and efficacy in a multicenter cohort. Gastric Cancer. 17(2). 341–347. 14 indexed citations

16.

Leclerc, Mathieu, P. Maingon, Marc Hamoir, et al.. (2013). A dose escalation study with intensity modulated radiation therapy (IMRT) in T2N0, T2N1, T3N0 squamous cell carcinomas (SCC) of the oropharynx, larynx and hypopharynx using a simultaneous integrated boost (SIB) approach. Radiotherapy and Oncology. 106(3). 333–340. 69 indexed citations

17.

Barret, Maximilien, David Malka, Thomas Aparicio, et al.. (2011). Nutritional Status Affects Treatment Tolerability and Survival in Metastatic Colorectal Cancer Patients: Results of an AGEO Prospective Multicenter Study. Oncology. 81(5-6). 395–402. 81 indexed citations

18.

Malet, Isabelle, Bénédicte Roquebert, Cécile Dalban, et al.. (2006). Association of Gag cleavage sites to protease mutations and to virological response in HIV-1 treated patients. Journal of Infection. 54(4). 367–374. 44 indexed citations

19.

Tubiana, Roland, Guislaine Carcelain, Muriel Vray, et al.. (2005). Therapeutic immunization with a human immunodeficiency virus (HIV) type 1-recombinant canarypox vaccine in chronically HIV-infected patients: The Vacciter Study (ANRS 094). Vaccine. 23(34). 4292–4301. 37 indexed citations

20.

Funck-Brentano, Isabelle, Cécile Dalban, Florence Veber, et al.. (2005). Evaluation of a peer support group therapy for HIV-infected adolescents. AIDS. 19(14). 1501–1508. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact